T1	Participants 33 75	antiretroviral-naïve HIV-infected patients
T2	Participants 525 554	antiretroviral-naïve patients
T3	Participants 575 709	136 antiretroviral-naïve patients, with a CD4 cell count above 100 cells/microL and a plasma HIV RNA below 100,000 HIV-1 RNA copies/mL
